Polypid Ltd

Research Polypid Ltd (PYPD) on Bullrun: market cap USD 95.30M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPYPD
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 95.30M
• Financial periodFY2025
• Net income-USD 34.17M
• Free cash flow-USD 28.09M

Valuation Snapshot

latest market cap is USD 95.30M.

About Polypid Ltd

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions.

Frequently asked questions

What is Polypid Ltd's market cap?

Polypid Ltd's market capitalization is USD 95.30M.

What does Polypid Ltd do?

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.